CASE REPORT |
|
Year : 2020 | Volume
: 26
| Issue : 3 | Page : 385--387 |
Respiratory muscle function and exercise capacity in a stage 4 head and neck cancer patient receiving chemoradiotherapy
Macrina D Souza1, Stephen Rajan Samuel1, Santosh PV Rai2, P U Prakash Saxena3, Gopala Krishna Alaparthi4
1 Department of Physiotherapy, KMC, Mangalore, Karnataka, India 2 Department of Radio Diagnosis, KMC, Mangalore, Karnataka, India 3 Department of Radiotherapy and Oncology, KMC, Mangalore, Manipal Academy of Higher Education, Mangalore, Karnataka, India 4 Department of Physiotherapy, College of Health Sciences, University of Sharjah, Sharjah, UAE
Correspondence Address:
Stephen Rajan Samuel Department of Physiotherapy, KMC, MAHE, Mangalore, Karnataka India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/IJPC.IJPC_210_19
Background: Reduced physical and functional capacity is one of the main treatment-related side effects of chemoradiation therapy in head-and-neck cancer patients. We evaluated a case of a head-and-neck cancer patient who was undergoing chemoradiation and was assessed for various components of cardiopulmonary function that plays a vital role in the treatment prognosis. The aim of this case report was to evaluate the respiratory muscle function and exercise capacity of a head-and-neck cancer patient receiving chemoradiation therapy. Settings and Design: From among the newly diagnosed admitted to the hospital care, a 60-year-old male with supraglottic carcinoma, who was undergoing concomitant chemoradiation for 7 weeks, was evaluated for various components of cardiopulmonary function. Subjects and Methods: Outcomes assessed were diaphragm function (mobility and thickness), maximal inspiratory pressure and maximal expiratory pressure, and 6-min walk test at baseline (pre), after 3 weeks, and after 7 weeks of chemoradiation therapy. The data were quantitatively analyzed to interpret the difference of respiratory muscle function and exercise capacity. Results: Evaluation of these outcomes showed a significant decrease from the baseline till the end of the 7th week. Conclusions: Therefore, concomitant chemoradiation therapy substantially decreased the respiratory muscle function and exercise capacity in the head-and-neck cancer patient.
[FULL TEXT] [PDF]*
|